Barinthus Biotherapeutics plc
BRNS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61 | -$73 | $5 | -$51 |
| Dep. & Amort. | $6 | $5 | $4 | $1 |
| Deferred Tax | -$0 | -$3 | -$4 | -$0 |
| Stock-Based Comp. | $5 | $5 | $10 | $16 |
| Change in WC | $3 | $6 | -$6 | -$7 |
| Other Non-Cash | $19 | $9 | -$24 | $9 |
| Operating Cash Flow | -$29 | -$51 | -$14 | -$33 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$5 | -$6 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | -$12 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$5 | -$6 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | $0 |
| Stock Issued | $2 | $2 | $0 | $103 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $120 |
| Financing Cash Flow | $2 | $2 | $0 | $223 |
| Forex Effect | -$2 | $2 | $0 | -$6 |
| Net Chg. in Cash | -$30 | -$52 | -$20 | $171 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $142 | $194 | $214 | $43 |
| End Cash | $112 | $142 | $194 | $214 |
| Free Cash Flow | -$30 | -$56 | -$21 | -$34 |